Published in

Wiley Open Access, Molecular Oncology, 2023

DOI: 10.1002/1878-0261.13416

Links

Tools

Export citation

Search in Google Scholar

ER +, HER2 − advanced breast cancer treated with taselisib and fulvestrant: genomic landscape and associated clinical outcomes

This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Green circle
Postprint: archiving allowed
Green circle
Published version: archiving allowed
Data provided by SHERPA/RoMEO